Longeveron Inc. (LGVN) Form 8-K — Oct 14, 2026

$LGVNForm 8-KItems 5.02Filed Oct 14, 2026, 4:01 PM ET0001213900-26-109411Original filing

Longeveron disclosed that Dr. Nataliya Agafonova is stepping down as Chief Medical Officer, effective October 14, 2026, per an Item 5.02 8-K. The filing does not name a successor or describe the reason for the departure. CEO Stephen Willard signed the report.

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.